针对状细胞血管病变的新型小分子治疗方法的发展
Gregory J Kato1, Mark T Gladwin
1Critical Care Medicine Department, Clinical Center, National Institutes of Health, 10 Center Dr, MSC 1476, Bldg 10-CRC, Room 5-5140, Bethesda, MD 20892-1476, USA. gkato@mail.nih.gov
状细胞疾病可能导致血解相关的血管病变,导致氧化缺乏和血管功能障碍. 这种综合症表现为中风,腿和肺高血压,促使新的治疗策略.
科学领域:
- 血管生物学 血管生物学
- 血液学 血液学 血液学
- 病理生理学 病理生理学
背景情况:
- 状细胞疾病 (SCD) 的特征是慢性血液溶解.
- 血液溶解通过吸收氧化 (NO) 导致内皮功能障碍.
更多相关视频
08:23Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
Published on: November 5, 2019
08:04In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
Published on: May 11, 2021
相关概念视频
Gene Therapy
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
iPS Cell Differentiation
Pharmacogenomics: Identification of New Drug Targets
Microorganisms in Medicine and Therapeutics
